CA2318772A1 - Techniques d'identification de sequences de polynucleotides et de polypeptides pouvant etre associees a des etats physiologiques et medicaux - Google Patents

Techniques d'identification de sequences de polynucleotides et de polypeptides pouvant etre associees a des etats physiologiques et medicaux Download PDF

Info

Publication number
CA2318772A1
CA2318772A1 CA002318772A CA2318772A CA2318772A1 CA 2318772 A1 CA2318772 A1 CA 2318772A1 CA 002318772 A CA002318772 A CA 002318772A CA 2318772 A CA2318772 A CA 2318772A CA 2318772 A1 CA2318772 A1 CA 2318772A1
Authority
CA
Canada
Prior art keywords
human
sequence
sequences
protein
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002318772A
Other languages
English (en)
Inventor
James M. Sikela
Walter Messier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evolutionary Genomics LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2318772A1 publication Critical patent/CA2318772A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1072Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1079Screening libraries by altering the phenotype or phenotypic trait of the host
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des techniques d'identification de séquences de polynucléotides et de polypeptides chez l'homme et/ou chez les autres primates qui peuvent être associées à un état physiologique, tel que la maladie (y compris la vulnérabilité (humaine) ou la résistance (chimpanzé) au développement du SIDA). Les techniques consistent à comparer entre elles les séquences humaines et celles des autres primates, à l'aide de méthodes statistiques. On peut se servir des séquences identifiées comme cibles thérapeutiques hôtes et/ou dans les analyses de criblage.
CA002318772A 1998-01-30 1999-01-29 Techniques d'identification de sequences de polynucleotides et de polypeptides pouvant etre associees a des etats physiologiques et medicaux Abandoned CA2318772A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7326398P 1998-01-30 1998-01-30
US60/073263 1998-01-30
US60/098987 1998-09-02
PCT/US1999/001964 WO1999039006A2 (fr) 1998-01-30 1999-01-29 Techniques d'identification de sequences de polynucleotides et de polypeptides pouvant etre associees a des etats physiologiques et medicaux

Publications (1)

Publication Number Publication Date
CA2318772A1 true CA2318772A1 (fr) 1999-08-05

Family

ID=22112723

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002318772A Abandoned CA2318772A1 (fr) 1998-01-30 1999-01-29 Techniques d'identification de sequences de polynucleotides et de polypeptides pouvant etre associees a des etats physiologiques et medicaux

Country Status (4)

Country Link
EP (1) EP1051519A2 (fr)
JP (1) JP2002501761A (fr)
CA (1) CA2318772A1 (fr)
WO (1) WO1999039006A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280953B1 (en) * 1998-01-30 2001-08-28 Evolutionary Genomics, L.L.C. Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
US6866996B1 (en) 1998-01-30 2005-03-15 Evolutionary Genomics, Llc Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
US7247425B2 (en) 1998-01-30 2007-07-24 Evolutionary Genomics, Llc Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
WO2005024066A1 (fr) * 2003-06-30 2005-03-17 Evolutionary Genomics Llc Methodes d'identification de sequences polynucleotidiques et polypeptidiques pouvant etre associees a des troubles physiologiques ou medicaux

Also Published As

Publication number Publication date
WO1999039006A3 (fr) 1999-11-04
EP1051519A2 (fr) 2000-11-15
WO1999039006A2 (fr) 1999-08-05
JP2002501761A (ja) 2002-01-22

Similar Documents

Publication Publication Date Title
US7462460B2 (en) Methods for identifying agents that increase the p44 function of microtubule assembly or resistance to HCV infection
US6228586B1 (en) Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
Rat Genome Sequencing Project Consortium DNA sequencing: Baylor College of Medicine Gibbs Richard A. agibbs@ bcm. tmc. edu 1 b Weinstock George M. 1 Metzker Michael L. 1 Muzny Donna M. 1 Sodergren Erica J. 1 Scherer Steven 1 Scott Graham 1 Steffen David 1 Worley Kim C. 1 Burch Paula E. 1 Okwuonu Geoffrey 1 Hines Sandra 1 Lewis Lora 1 DeRamo Christine 1 Delgado Oliver 1 Dugan-Rocha Shannon 1 Miner George 1 Morgan Margaret 1 Hawes Alicia 1 Gill Rachel 1 Holt Celera Robert A. 2 3 Adams Mark D. 3 4 Amanatides Peter G. 3 5 Baden-Tillson Holly 3 6 Barnstead Mary 3 7 Chin Soo 3 Evans Cheryl A. 3 Ferriera Steve 3 8 Fosler Carl 3 Glodek Anna 3 9 Gu Zhiping 3 Jennings Don 3 Kraft Cheryl L. 3 10 Nguyen Trixie 3 Pfannkoch Cynthia M. 3 6 Sitter Cynthia 3 11 Sutton Granger G. 3 Venter J. Craig 3 8 Woodage Trevor 3 Genome Therapeutics Smith Douglas 12 13 Lee Hong-Mei 12 Gustafson Erik 12 13 Cahill Patrick 12 Kana Arnold 12 Doucette-Stamm Lynn 12 13 Weinstock Keith 12 Fechtel Kim 12 et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution
US20090304653A1 (en) Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
AU2003245488A8 (en) Functional sites
JPS58130000A (ja) HLA型判定法とそれに使用するcDNAプロ−ブ
JP2004512812A (ja) 特発性全身てんかんについてのローカス、当該ローカスのミューテーション、及びてんかんの評価、診断、予後、または治療のための当該ローカスの使用方法
JPH03133400A (ja) 核酸誘導体
US6743580B2 (en) Methods for producing transgenic plants containing evolutionarily significant polynucleotides
US6280953B1 (en) Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
US20080003607A1 (en) Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
AU2001275303A1 (en) Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
CA2318772A1 (fr) Techniques d'identification de sequences de polynucleotides et de polypeptides pouvant etre associees a des etats physiologiques et medicaux
US7247425B2 (en) Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
WO2000012764A9 (fr) Techniques permettant d'identifier des sequences de polynucleotides et de polypeptides associees a des etats physiologiques et medicaux
EP1250449B1 (fr) Procedes pour identifier des changements evolutionnaires importants dans des sequences de polynucleotides et de polypeptides chez des plantes et des animaux domestiques
AU2007202866A1 (en) Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
EP2048249A1 (fr) Procédés pour identifier des séquences de polynucléotides et polypeptides pouvant être associées avec des états physiologiques et médicaux
Oefner Sequence variation and the biological function of genes: methodological and biological considerations
Vrana et al. Molecular evolution and phylogenetic utility of the polyubiquitin locus in mammals and higher vertebrates
AU2003298556A8 (en) Functional sites
WO2005079196A2 (fr) Methodes pour identifier des changements considerables d'evolution dans des sequences polynucleotidiques et polypeptidiques de procaryotes
WO2004031397A9 (fr) Detection de goulots d'etranglements dans l'evolution par sequençage d'adn en tant que methode de decouverte de genes de valeur

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead